Abstract

A new series of 2-amino-1,4-naphthoquinone-benzamides 5a-n was designed based on previously reported potent cytotoxic agents. These compounds were synthesized from the reaction of 1,4-naphthoquinone, 4-aminobenzoic acid, and appropriate amine derivatives in good yields. Cytotoxic activities of the target compounds 5a-n were evaluated against three cancer cell lines MDA-MB-231, SUIT-2, and HT-29 by MTT assay and the obtained in vitro data. All newly synthesized compounds were more potent than positive control cisplatin against MDA-MB-231 cell line and less potent than this control against SUIT-2 cell line. Moreover, most of the synthesized compounds were more potent than cisplatin against HT-29 cell line. Among the synthesized compounds, compound 5e was the most potent cytotoxic agent against all the three evaluated cell lines. Moreover, cell cycle analysis showed that derivatives 5f and 5l dose-dependently increase the percentage of sub-G1 cells. Induction of apoptosis as an important mechanism of anti-cancer drugs was confirmed morphologically in the most potent new compounds 5e, 5f, 5g, and 5l by Hoechst 33,258 staining.

Details

Title
Design, synthesis, and cytotoxic activity of 2-amino-1,4-naphthoquinone-benzamide derivatives as apoptosis inducers
Author
Sayahi, Mohammad Hosein 1 ; Hassani, Bahareh 2 ; Mohammadi-Khanaposhtani, Maryam 3 ; Dastyafteh, Navid 4 ; Gohari, Mohammad Reza 4 ; Tehrani, Mohammadreza Mohajeri 4 ; Larijani, Bagher 4 ; Mahdavi, Mohammad 4 ; Firuzi, Omidreza 2 

 Payame Noor University, Department of Chemistry, Tehran, Iran (GRID:grid.412462.7) (ISNI:0000 0000 8810 3346) 
 Shiraz University of Medical Sciences, Medicinal and Natural Products Chemistry Research Center, Shiraz, Iran (GRID:grid.412571.4) (ISNI:0000 0000 8819 4698) 
 Babol University of Medical Sciences, Cellular and Molecular Biology Research Center, Health Research Institute, Babol, Iran (GRID:grid.411495.c) (ISNI:0000 0004 0421 4102) 
 Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922) 
Pages
27302
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3126245641
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.